Shikone T, Matzuk M M, Perlas E, Finegold M J, Lewis K A, Vale W, Bradley A, Hsueh A J
Department of Gynecology and Obstetrics, Stanford University Medical Center, California 94305-5317.
Mol Endocrinol. 1994 Aug;8(8):983-95. doi: 10.1210/mend.8.8.7997239.
Inhibin-alpha-deficient mutant mice have been generated by a targeted deletion of the inhibin-alpha gene through homologous recombination in murine embryonic stem cells. Essentially all of the homozygous mutants develop gonadal sex cord-stromal tumors. To investigate their endocrine and proliferative characteristics, gonadal tumor cells were maintained in vitro. Cells from inhibin-alpha-deficient mice multiplied poorly; however, cells from mice deficient in both inhibin-alpha and p53 proliferated rapidly and showed higher saturation density and plating efficiency, thus allowing the establishment of clonal tumor cell lines. Although negligible estrogen and testosterone was produced by the clonal cells, high levels of progesterone were secreted. A clonal testis tumor cell line (inhibin-alpha/p53 deficient) showed no response to exogenous FSH, human CG (hCG), or inhibin A but exhibited a 6- to 8-fold increase in progesterone production in response to forskolin treatment. The stimulatory effect of forskolin was, however, partially blocked by activin treatment. Northern blot analysis revealed inhibin beta A and beta B mRNA expression in these cells. Furthermore, Western blot analyses indicated the secretion of the beta A-subunit protein. We further tested the role of activin on tumor cell growth. Treatment with follistatin, an activin-binding protein, inhibited tumor cell replication in a dose-dependent manner. In contrast, treatment with activin A stimulated tumor cell growth by itself and partially blocked follistatin action. Incorporation of thymidine into DNA of these cells was also stimulated by activin. In addition, treatment with antiactivin A serum inhibited tumor cell replication and blocked the stimulatory action of activin on cell growth. The activin action is likely mediated by specific receptors because cross-linking of [125]activin to the 50-55 kilodalton type I and 75-80 kilodalton type II receptors was found using sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. Northern blot analysis also revealed follistatin mRNA expression in the tumor cells, suggesting these cells are related to granulosa cells. Our findings indicate that activin can act as an autocrine growth factor in stimulating the proliferation of gonadal tumor cell lines derived from inhibin-alpha and p53-deficient mice and inhibits progesterone production. These tumor cell lines are useful for studies on the regulation of gonadal cell proliferation and steroidogenesis as well as the signaling pathway mediating activin action.
通过在小鼠胚胎干细胞中进行同源重组,定向缺失抑制素α基因,从而构建出抑制素α基因缺陷的突变小鼠。基本上所有纯合突变体都会发生性腺性索间质肿瘤。为了研究其内分泌和增殖特性,对性腺肿瘤细胞进行了体外培养。来自抑制素α基因缺陷小鼠的细胞增殖能力较差;然而,来自同时缺乏抑制素α和p53的小鼠的细胞增殖迅速,并且显示出更高的饱和密度和平板接种效率,因此能够建立克隆肿瘤细胞系。尽管克隆细胞产生的雌激素和睾酮可忽略不计,但却分泌高水平的孕酮。一个克隆性睾丸肿瘤细胞系(抑制素α/p53缺陷型)对外源性促卵泡激素、人绒毛膜促性腺激素(hCG)或抑制素A无反应,但对福司可林处理有反应,孕酮分泌增加6至8倍。然而,福司可林的刺激作用被激活素处理部分阻断。Northern印迹分析显示这些细胞中存在抑制素βA和βB mRNA表达。此外,Western印迹分析表明有βA亚基蛋白的分泌。我们进一步测试了激活素对肿瘤细胞生长的作用。用激活素结合蛋白卵泡抑素处理,以剂量依赖方式抑制肿瘤细胞复制。相反,用激活素A处理本身可刺激肿瘤细胞生长,并部分阻断卵泡抑素的作用。胸腺嘧啶掺入这些细胞的DNA也受到激活素的刺激。此外,用抗激活素A血清处理可抑制肿瘤细胞复制,并阻断激活素对细胞生长的刺激作用。激活素的作用可能由特定受体介导,因为使用十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳分析发现[125]激活素与50 - 55千道尔顿的I型和75 - 80千道尔顿的II型受体发生交联。Northern印迹分析还显示肿瘤细胞中有卵泡抑素mRNA表达,表明这些细胞与颗粒细胞有关。我们的研究结果表明,激活素可作为自分泌生长因子,刺激源自抑制素α和p53缺陷小鼠的性腺肿瘤细胞系的增殖,并抑制孕酮产生。这些肿瘤细胞系可用于研究性腺细胞增殖和类固醇生成的调节以及介导激活素作用的信号通路。